BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16632016)

  • 1. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.
    Taylor EN; Mount DB; Forman JP; Curhan GC
    Am J Kidney Dis; 2006 May; 47(5):780-9. PubMed ID: 16632016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis.
    Eisner BH; Porten SP; Bechis SK; Stoller ML
    J Urol; 2010 Feb; 183(2):576-9. PubMed ID: 20018328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary citrate excretion in idiopathic nephrolithiasis.
    Ratan SK; Bhatnagar V; Mitra DK; Basu N; Malhotra LK
    Indian Pediatr; 2002 Sep; 39(9):819-25. PubMed ID: 12368525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalate intake and the risk for nephrolithiasis.
    Taylor EN; Curhan GC
    J Am Soc Nephrol; 2007 Jul; 18(7):2198-204. PubMed ID: 17538185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased acid excretion in kidney stone formers with essential hypertension.
    Losito A; Nunzi EG; Covarelli C; Nunzi E; Ferrara G
    Nephrol Dial Transplant; 2009 Jan; 24(1):137-41. PubMed ID: 18715964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 2001 Mar; 101(3):326-31. PubMed ID: 11269613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased urinary citrate excretion in type 1a glycogen storage disease.
    Weinstein DA; Somers MJ; Wolfsdorf JI
    J Pediatr; 2001 Mar; 138(3):378-82. PubMed ID: 11241046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
    Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
    J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
    Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease.
    Mente A; Honey RJ; McLaughlin JM; Bull SB; Logan AG
    J Am Soc Nephrol; 2006 Sep; 17(9):2567-75. PubMed ID: 16855017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.